Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.

Saved in:
Bibliographic Details
Title: Allogeneic hematopoietic SCT in patients with AML following treosulfan/fludarabine conditioning.
Authors: Casper J; Division of Hematology and Oncology, University of Rostock, Rostock, Germany. casper.jochen@klinikum-oldenburg.de, Holowiecki J, Trenschel R, Wandt H, Schaefer-Eckart K, Ruutu T, Volin L, Einsele H, Stuhler G, Uharek L, Blau I, Bornhaeuser M, Zander AR, Larsson K, Markiewicz M, Giebel S, Kruzel T, Mylius HA, Baumgart J, Pichlmeier U, Freund M, Beelen DW
Source: Bone marrow transplantation [Bone Marrow Transplant] 2012 Sep; Vol. 47 (9), pp. 1171-7. Date of Electronic Publication: 2011 Dec 12.
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1476-5365
DOI:10.1038/bmt.2011.242